AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Neuropiln 1 (Nrp1) Modulation for Immune System Control (SJ-13-0012)

Detailed Technology Description
Description Boosting the ability of regulatory T cells by blocking an effective anti-tumor immune response led to the elimination or dramatic reduction of melanoma by the immune system in mice, without causing the autoimmune and inflammatory problems often associated with current cancer-treatment efforts that target immune regulators. The mechanism is built around two proteins. One, semaphorin-4a (Sema4a), is carried on the surface of various immune cells that can spark inflammation. The other, neuropilin-1 (Nrp1), is carried on the surface of regulatory T cells.
*Abstract

Granted Patents or Published Applications
Related Scientific References 'Regulatory T cell stability is maintained by a neuropilin-1:semaphorin-4a axis' is published on Nature.com: http://dx.doi.org/10.1038/nature12428. (Abstracts are available to everyone, full text only to subscribers; relevant references are cited in the paper and can be provided on request)

Country/Region
USA

For more information, please click Here
Mobile Device